IGA GEN.2, COBAS C503
Received Aug 9, 2021 · Event occurred Jul 14, 2021
Report 1823260-2021-02316 · MDR key 12297557
Device
Generic name
Immunoglobulin A
Manufacturer
Roche DiagnosticsModel number
NACatalog number
08057885190
Lot number
49318101
Product problems
- Low Test Results
- Low Test Results
Patient
63 YR
- No Clinical Signs, Symptoms or Conditions
- No Clinical Signs, Symptoms or Conditions
Narrative
Additional Manufacturer Narrative
BOTH SAMPLES WERE RECEIVED FOR INVESTIGATION AND TESTED WITH IGA-2 REAGENT LOT 493181 ON A C503 ANALYZER. THE CUSTOMER'S RESULTS WERE PARTIALLY REPRODUCED AT THE INVESTIGATION SITE. THE NORMAL MEASUREMENT OF EACH SAMPLE PRODUCED SAMPLE FLAGS WITH NO NUMERIC RESULT. WHEN THE SAMPLE WAS AUTOMATICALLY DILUTED 1:10 AND 1:20 THE SAME SAMPLE FLAG WITH NO NUMERIC RESULT WAS PRODUCED. WHEN THE SAMPLE WAS RUN IN DECREASED MODE, VALID RESULTS WERE RECEIVED: 62.8 G/L (SAMPLE 1) AND 65.6 G/L (SAMPLE 2). WHEN THE SAMPLE WAS MANUALLY DILUTED, VALID RESULTS WERE RECEIVED: 6.14 G/L (SAMPLE 1, 1:10), 3.21 G/L (SAMPLE 1, 1:20) AND 6.34 G/L (SAMPLE 2, 1:10), 3.31 (SAMPLE 2, 1:20). SAMPLE 1 SHOWED A VERY HIGH HEMOLYSIS (H) INDEX OF 833. THE SAMPLE FLAG RECEIVED INDICATES A HIGH IGA CONCENTRATION IN THE SAMPLE THAT EXCEEDS THE UPPER LIMIT OF THE PRIMARY MEASURING RANGE OF 8 MG/L. THE RESULTS FROM THE INVESTIGATION IN DECREASED MODE AND THE RESULTS MANUALLY DILUTED CORRELATE WELL TO THE RESULTS OF 60 G/L FOR BOTH SAMPLES AND ALSO MATCH THE CUSTOMER'S ELECTROPHORESIS RESULTS. THE CUSTOMER'S LOW RESULT OF 0.827 G/L WAS DUE TO CLOTS IN THE PRIMARY TUBE OF THE SAMPLE THAT WAS RE-CENTRIFUGED AND ALIQUOTED FOR FURTHER MEASUREMENTS; THE NEEDLE WAS BLOCKED CAUSING AN INSUFFICIENT AMOUNT OF SAMPLE MATERIAL TO BE PIPETTED. THE CUSTOMER MAY HAVE ORDERED THE SAMPLE RERUNS BY 1:10 AUTOMATIC DILUTION. IF AN AUTOMATIC DILUTION WITH A FACTOR IS REQUESTED ON THE INSTRUMENT FOR IGA, THE PRE-DILUTION OF THE TEST IS CANCELLED, RESULTING IN AN INCREASED CONCENTRATION. THE INVESTIGATION DETERMINED THE EVENT WAS DUE TO PRE-ANALYTICAL HANDLING ISSUES AND A CUSTOMER HANDLING ERROR DURING REPEAT TESTING IN DILUTION MODE.
Additional Manufacturer Narrative
BOTH SAMPLES FROM THE PATIENT WERE REQUESTED FOR INVESTIGATION.
Description of Event or Problem
THE INITIAL REPORTER COMPLAINED OF DISCREPANT RESULTS FOR 1 PATIENT SAMPLE TESTED FOR TINA-QUANT IGA GEN.2 (IGA-2) ON A COBAS PRO C 503 ANALYTICAL UNIT. THE INITIAL RUN OF THE PATIENT SAMPLE FROM THE PRIMARY TUBE PRODUCED AN ALARM WITH NO NUMERIC RESULT. THE SAMPLE WAS RE-CENTRIFUGED AND REPEATED IN A CUP AND ANOTHER ALARM WAS RECEIVED WITH NO NUMERIC RESULT. THE SAMPLE WAS REPEATED AND THE RESULT WAS 0.827 G/L. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. ON (B)(6) 2021 THE DOCTOR COMPLAINED THAT THE LOW RESULT WAS NOT PLAUSIBLE. THIS WAS ALSO CONFIRMED BY THE RESULTS FROM ELECTROPHORESIS AND IMMUNOFIXATION TESTING. ON (B)(6) 2021 THE CUSTOMER REPEATED THE ORIGINAL SAMPLE TWICE WITH RESULTS OF 96.4 G/L WITH A DATA FLAG AND 97.8 G/L WITH A DATA FLAG. ON (B)(6) 2021 A NEW SAMPLE WAS OBTAINED AND THE INITIAL RESULT WAS 94.7 G/L WITH A DATA FLAG. THIS SAMPLE WAS REPEATED WITH A RESULT OF 65.4 G/L WITH A DATA FLAG. ON (B)(6) 2021 THE ORIGINAL SAMPLE WAS RUN AGAIN AND THE RESULT WAS 463 G/L WITH A DATA FLAG AND THE REPEAT WAS 67.0 G/L WITH A DATA FLAG. THIS SAMPLE WAS ALSO RUN BY A 1:10 DILUTION WITH CALCULATED RESULTS OF 62.8 G/L AND 66.0 G/L. THE CUSTOMER STATED BOTH SAMPLES WERE HEMOLYTIC. ALL INITIAL RESULTS WERE RUN IN NORMAL MODE AND THE REPEAT TESTS WERE BY AUTOMATIC REPEAT WITH DECREASED SAMPLE VOLUME. THE C503 UNIT SERIAL NUMBER WAS (B)(4).